{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T20:38:40Z","timestamp":1782160720838,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["IUT 42\u20132"],"award-info":[{"award-number":["IUT 42\u20132"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","award":["SMVBS21328T"],"award-info":[{"award-number":["SMVBS21328T"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","award":["SMVBS22064"],"award-info":[{"award-number":["SMVBS22064"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007821","name":"Tartu \u00dclikool","doi-asserted-by":"publisher","award":["327\/M-14"],"award-info":[{"award-number":["327\/M-14"]}],"id":[{"id":"10.13039\/501100007821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jgar.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T02:47:21Z","timestamp":1677725241000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4641-2695","authenticated-orcid":false,"given":"Arina","family":"\u0160ablinskaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merit","family":"Pauskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-0951","authenticated-orcid":false,"given":"Ene-Ly","family":"J\u00f5geda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Rajasaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilleriin","family":"Soodla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveli","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Velts-Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-5722","authenticated-orcid":false,"given":"Ruth","family":"K\u00fc\u00fcsmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zilmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"R\u00fc\u00fctel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7606-675X","authenticated-orcid":false,"given":"Taavi","family":"P\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irja","family":"Lutsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Huik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radko","family":"Avi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2023.02.009_bib0001","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"Hofstra","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.846943","article-title":"Trends of transmitted and acquired drug resistance in Europe from 1981 to 2019: a comparison between the populations of late presenters and non-late presenters","volume":"13","author":"Miranda","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2023.02.009_bib0003","doi-asserted-by":"crossref","first-page":"e25611","DOI":"10.1002\/jia2.25611","article-title":"HIV-1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates","volume":"23","author":"Rhee","year":"2020","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.jgar.2023.02.009_bib0004","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jgar.2023.02.009_bib0005","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.19.1800390","article-title":"Piloting a surveillance system for HIV drug resistance in the European Union","volume":"24","author":"van de Laar","year":"2019","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2023.02.009_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/aid.2018.0213","article-title":"Integrase strand transfer inhibitor resistance mutations in antiretroviral therapy-naive and treatment-experienced HIV patients in South Korea","volume":"35","author":"Jeong","year":"2019","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2023.02.009_bib0007","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/1570162X15666170815162052","article-title":"HIV type 1 integrase natural polymorphisms in viral variants circulating in FSU countries","volume":"15","author":"Lapovok","year":"2017","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.jgar.2023.02.009_bib0008","first-page":"ciab583","article-title":"Transmitted drug resistance among HIV-1 diagnoses in the United States, 2014\u20132018","author":"McClung","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0009","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1097\/QAD.0000000000001611","article-title":"Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016","volume":"31","author":"Menza","year":"2017","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.jgar.2023.02.009_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1201-9712(02)90131-1","article-title":"The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia","volume":"6","author":"Uusk\u00fcla","year":"2002","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0011","first-page":"598","article-title":"Predominance of a rare type of HIV-1 in Estonia","volume":"39","author":"Adojaan","year":"2005","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"10.1016\/j.jgar.2023.02.009_bib0012","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1089\/aid.2004.20.1148","article-title":"Two viral strains and a possible novel recombinant are responsible for the explosive injecting drug use-associated HIV type 1 epidemic in Estonia","volume":"20","author":"Zetterberg","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2023.02.009_bib0013","series-title":"European Meeting on HIV and Hepatitis","article-title":"The patterns of integrase strand transfer inhibitors drug resistance mutations in HIV-1 CRF06_cpx in Estonia","author":"Pauskar","year":"2018"},{"key":"10.1016\/j.jgar.2023.02.009_bib0014","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/jmv.21482","article-title":"Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia","volume":"81","author":"Avi","year":"2009","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgar.2023.02.009_bib0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/00365548.2010.526956","article-title":"Emerging transmitted drug resistance in treatment-na\u00efve human immunodeficiency virus-1 CRF06_cpx-infected patients in Estonia","volume":"43","author":"Avi","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0016","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/aid.2012.0357","article-title":"Transmitted drug resistance is still low in newly diagnosed human immunodeficiency virus type 1 CRF06_cpx-infected patients in Estonia in 2010","volume":"30","author":"Avi","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2023.02.009_bib0017","article-title":"Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy","author":"Soodla","year":"2019","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0018","unstructured":"Republic of Estonia Health Board. https:\/\/www.terviseamet.ee\/en (accessed October 10, 2019)."},{"key":"10.1016\/j.jgar.2023.02.009_bib0019","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3109\/23744235.2015.1061203","article-title":"Design and structure of the Estonian HIV Cohort Study (E-HIV)","volume":"47","author":"Soodla","year":"2015","journal-title":"Infect Dis Lond Engl"},{"key":"10.1016\/j.jgar.2023.02.009_bib0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1468-1293.2009.00747.x","article-title":"Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment","volume":"11","author":"Murillo","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jgar.2023.02.009_bib0021","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/135965350701200411","article-title":"Natural polymorphism of the HIV-1 integrase gene and mutations associated with integrase inhibitor resistance","volume":"12","author":"Lataillade","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jgar.2023.02.009_bib0022","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/088922299311475","article-title":"Virtually full-length sequences of HIV type 1 subtype J reference strains","volume":"15","author":"Laukkanen","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jgar.2023.02.009_bib0023","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/viro.1995.1548","article-title":"Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction","volume":"213","author":"Salminen","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.jgar.2023.02.009_bib0024","first-page":"337","article-title":"Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools","volume":"19","author":"Pineda-Pe\u00f1a","year":"2013","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.jgar.2023.02.009_bib0026","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/bioinformatics\/btp134","article-title":"The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance","volume":"25","author":"Gifford","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jgar.2023.02.009_bib0027","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkz417","article-title":"Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance","volume":"75","author":"Tzou","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.009_bib0028","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0029","doi-asserted-by":"crossref","first-page":"20673","DOI":"10.2807\/1560-7917.ES2014.19.2.20673","article-title":"Recent infection testing algorithm (RITA) applied to new HIV diagnoses in England, Wales and Northern Ireland, 2009 to 2011","volume":"19","author":"Aghaizu","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2023.02.009_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0956462417714635","article-title":"Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia","volume":"29","author":"Chan","year":"2018","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jgar.2023.02.009_bib0031","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10461-010-9777-x","article-title":"A Surveillance report of HIV status and high risk behaviors among rapid testing participants in Tallinn, Estonia","volume":"15","author":"Parker","year":"2011","journal-title":"AIDS Behav"},{"key":"10.1016\/j.jgar.2023.02.009_bib0032","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/01.aids.0000247586.23696.20","article-title":"High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment","volume":"20","author":"Platt","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jgar.2023.02.009_bib0033","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1093\/jac\/dkz067","article-title":"Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice","volume":"74","author":"Alvarez","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.009_bib0034","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jmv.25896","article-title":"Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy","volume":"92","author":"Calza","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.jgar.2023.02.009_bib0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/v12080838","article-title":"Genetic features of HIV-1 integrase sub-subtype A6 predominant in Russia and predicted susceptibility to INSTIs","volume":"12","author":"Kirichenko","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2023.02.009_bib0036","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1093\/jac\/dkaa309","article-title":"Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK","volume":"75","author":"Mbisa","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2023.02.009_bib0037","first-page":"122","article-title":"Differences in the integrase and reverse transcriptase transmitted resistance patterns in northern Poland","volume":"49","author":"Parczewski","year":"2017","journal-title":"Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis"},{"key":"10.1016\/j.jgar.2023.02.009_bib0038","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s15010-016-0936-5","article-title":"Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013","volume":"45","author":"Zoufaly","year":"2017","journal-title":"Infection"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716523000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:01:26Z","timestamp":1761991286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716523000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":38,"alternative-id":["S2213716523000255"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.009","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}